4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-041790
CEO and Chairman sold 30,000 shares at an average $38.47 ($1,153,965)
From the SEC's structured data for this filing
Trades in this filing
ROBINS CHAD M · CEO and Chairman
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-06-15 | Sale : show line 1 in the form | −19,100 | $38.22 | $730,002 | 1,729,361 | D |
| 2021-06-15 | Sale : show line 2 in the form | −900 | $39.23 | $35,307 | 1,728,461 | D |
| 2021-06-16 | Sale : show line 3 in the form | −4,745 | $38.13 | $180,927 | 1,723,716 | D |
| 2021-06-17 | Sale : show line 4 in the form | −1,000 | $38.55 | $38,550 | 1,722,716 | D |
| 2021-06-17 | Sale : show line 5 in the form | −4,255 | $39.76 | $169,179 | 1,718,461 | D |
| Open-market sales · 30,000 sh · avg $38.47 · $1,153,965 | ||||||
Loading xslF345X03/doc4.xml…